Add BrightSurf on Google Email

Science News for August 29, 2010


Heart-rate-lowering drug ivabradine reduces death and hospitalization when added to standard treatments in patients with heart failure

The SHIFT study found that ivabradine significantly reduced cardiovascular death and hospitalization for worsening heart failure when added to standard treatment in patients with a high heart rate. Lowering heart rates with ivabradine was also associated with improved clinical outcomes, including an average reduction of 15 bpm.

SourceThe Lancet_DELETED·JournalThe Lancet·DateAug 29, 2010

All genes in 1 go

Scientists at Max Planck Institute successfully analyze all genes in human genome simultaneously to identify mutation causing Mabry Syndrome. The new process reveals a mutation in PIGV gene leading to mental retardation and other symptoms.

SourceMax-Planck-Gesellschaft·JournalNature Genetics·DateAug 29, 2010

Genetic variation in key cell pumping mechanism reduces effects of clopidogrel treatment (but not prasugrel), leaving those affected at increased risk of cardiovascular events

A study found that genetic variation in ABCB1 affects clopidogrel metabolism, leading to increased cardiovascular risk. The variation, which is common in half the population, can render standard clopidogrel treatment less effective, highlighting the importance of personalized medicine approaches.

SourceThe Lancet_DELETED·JournalThe Lancet·DateAug 29, 2010